We are pleased to announce the publication of our latest research in Gut, describing the development of C9-66 CAR-T cells targeting oncofetal chondroitin sulfate (ofCS) in pancreatic ductal adenocarcinoma (PDAC). PDAC is one of the most aggressive solid tumors, and one where effective treatments remain limited. ofCS is expressed across a range of solid tumors […]
